Pure Bioscience, Inc. (PURE) stock
PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31
$0.07−0.01 (-12.10%)
Close on Oct 19, 2026Market cap $8.67MP/E –Yield –
Pure Bioscience total assets
Total assets on the balance sheet at the end of each period.
Pure Bioscience's total assets was $1.19M at Jul 31, 2026. For fiscal 2026 it was $1.19M, up 12.8% from the year before. Over ten years it grew -16.9% a year on average. The highest annual figure on record is $7.56M in fiscal 2016.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jul 31, 2026 | $1.19M | +12.8% |
| FY2025 | Jul 31, 2025 | $1.06M | +29.3% |
| FY2024 | Jul 31, 2024 | $818.00K | -55.2% |
| FY2023 | Jul 31, 2023 | $1.83M | -59.3% |
| FY2022 | Jul 31, 2022 | $4.48M | +4.2% |
| FY2021 | Jul 31, 2021 | $4.30M | -31.9% |
| FY2020 | Jul 31, 2020 | $6.32M | +227.3% |
| FY2019 | Jul 31, 2019 | $1.93M | -25.0% |
| FY2018 | Jul 31, 2018 | $2.58M | -32.8% |
| FY2017 | Jul 31, 2017 | $3.83M | -49.4% |
| FY2016 | Jul 31, 2016 | $7.56M | +131.9% |
| FY2015 | Jul 31, 2015 | $3.26M | +75.4% |
| FY2014 | Jul 31, 2014 | $1.86M | -9.8% |
| FY2013 | Jul 31, 2013 | $2.06M | -53.7% |
| FY2012 | Jul 31, 2012 | $4.46M | -13.4% |
| FY2011 | Jul 31, 2011 | $5.15M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jul 31, 2026 | $1.19M | +12.8% |
| Q3 FY2026CQ1 2026 | Apr 30, 2026 | $1.56M | +47.4% |
| Q2 FY2026CQ4 2025 | Jan 31, 2026 | $788.00K | +37.3% |
| Q1 FY2026CQ3 2025 | Oct 31, 2025 | $1.19M | +28.4% |
| Q4 FY2025CQ2 2025 | Jul 31, 2025 | $1.06M | +29.3% |
| Q3 FY2025CQ1 2025 | Apr 30, 2025 | $1.06M | +14.9% |
| Q2 FY2025CQ4 2024 | Jan 31, 2025 | $574.00K | -47.1% |
| Q1 FY2025CQ3 2024 | Oct 31, 2024 | $924.00K | -58.9% |
| Q4 FY2024CQ2 2024 | Jul 31, 2024 | $818.00K | -55.2% |
| Q3 FY2024CQ1 2024 | Apr 30, 2024 | $920.00K | -49.6% |
| Q2 FY2024CQ4 2023 | Jan 31, 2024 | $1.09M | -57.1% |
| Q1 FY2024CQ3 2023 | Oct 31, 2023 | $2.25M | -39.2% |
| Q4 FY2023CQ2 2023 | Jul 31, 2023 | $1.83M | -59.3% |
| Q3 FY2023CQ1 2023 | Apr 30, 2023 | $1.82M | -13.9% |
| Q2 FY2023CQ4 2022 | Jan 31, 2023 | $2.53M | -9.3% |
| Q1 FY2023CQ3 2022 | Oct 31, 2022 | $3.70M | +4.1% |
| Q4 FY2022CQ2 2022 | Jul 31, 2022 | $4.48M | +4.2% |
| Q3 FY2022CQ1 2022 | Apr 30, 2022 | $2.12M | -56.3% |
| Q2 FY2022CQ4 2021 | Jan 31, 2022 | $2.79M | -47.2% |
| Q1 FY2022CQ3 2021 | Oct 31, 2021 | $3.56M | -38.3% |
| Q4 FY2021CQ2 2021 | Jul 31, 2021 | $4.30M | -31.9% |
| Q3 FY2021CQ1 2021 | Apr 30, 2021 | $4.85M | +1.3% |
| Q2 FY2021CQ4 2020 | Jan 31, 2021 | $5.29M | +260.1% |
| Q1 FY2021CQ3 2020 | Oct 31, 2020 | $5.77M | +158.6% |
| Q4 FY2020CQ2 2020 | Jul 31, 2020 | $6.32M | +227.3% |
| Q3 FY2020CQ1 2020 | Apr 30, 2020 | $4.79M | +179.9% |
| Q2 FY2020CQ4 2019 | Jan 31, 2020 | $1.47M | -17.4% |
| Q1 FY2020CQ3 2019 | Oct 31, 2019 | $2.23M | -12.2% |
| Q4 FY2019CQ2 2019 | Jul 31, 2019 | $1.93M | -25.0% |
| Q3 FY2019CQ1 2019 | Apr 30, 2019 | $1.71M | -38.9% |
| Q2 FY2019CQ4 2018 | Jan 31, 2019 | $1.78M | -55.3% |
| Q1 FY2019CQ3 2018 | Oct 31, 2018 | $2.54M | -51.2% |
| Q4 FY2018CQ2 2018 | Jul 31, 2018 | $2.58M | -32.8% |
| Q3 FY2018CQ1 2018 | Apr 30, 2018 | $2.80M | -43.0% |
| Q2 FY2018CQ4 2017 | Jan 31, 2018 | $3.97M | -35.0% |
| Q1 FY2018CQ3 2017 | Oct 31, 2017 | $5.21M | -18.7% |
| Q4 FY2017CQ2 2017 | Jul 31, 2017 | $3.83M | – |
| Q3 FY2017CQ1 2017 | Apr 30, 2017 | $4.91M | – |
| Q2 FY2017CQ4 2016 | Jan 31, 2017 | $6.11M | – |
| Q1 FY2017CQ3 2016 | Oct 31, 2016 | $6.40M | – |
See a number that looks wrong?